Answers are grounded in this paper and cite their sources.
Background Laryngeal squamous cell carcinoma (LSCC) is an aggressive malignancy with poor prognosis, and identifying key drivers within its tumor microenvironment remains critical for biomarker discovery and therapeutic targeting. Methods Single-cell RNA sequencing data from GSE206332 were analyzed to identify M2 macrophage-associated subgroups. LASSO-Cox regression was applied to the TCGA-LSCC cohort to screen prognostic genes, identifying Peroxiredoxin 4 (PRDX4) as the core candidate. PRDX4 expression was validated in LSCC clinical samples and cell lines using qRT-PCR and Western blot. Somatic mutation profiles were characterized using maftools, and the association between PRDX4 expression and tumor mutational burden (TMB) was assessed. An exploratory germline cis-expression quantitative trait locus (cis-eQTL) analysis using GTEx data was performed to characterize potential inherited regulatory associations with PRDX4 expression in normal tissues. Functional enrichment, immune infiltration, TIDE-related analyses, and CellChat analysis were conducted to characterize PRDX4-associated biological pathways and intercellular communication. Results Single-cell analysis identified a Macro_C1QC macrophage subgroup with M2-like polarization features. PRDX4 was significantly upregulated in LSCC and showed moderate diagnostic discriminatory ability, with an AUC of 0.697. Univariate and multivariate Cox analyses confirmed PRDX4 as an independent prognostic factor for overall survival. Somatic mutation analysis showed that PRDX4 expression was significantly elevated in the high-TMB group and positively correlated with TMB. Exploratory GTEx cis-eQTL analysis identified 423 PRDX4-associated variants across 35 normal tissues, with rs518857 showing a directionally consistent positive association with PRDX4 expression across several tissues. GSEA indicated enrichment of the complement and coagulation cascade pathway in the high-PRDX4 group, while CellChat analysis suggested enhanced SPP1–CD44 signaling. Conclusion Integrated multi-omics analyses identify PRDX4 as a candidate prognostic biomarker associated with M2 macrophage-related features in LSCC. Elevated PRDX4 expression is associated with poor survival, and its potential functional role warrants further mechanistic investigation.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: